Adell Harriman & Carpenter’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-3,621
Closed -$484K 152
2018
Q4
$484K Sell
3,621
-4,069
-53% -$667K 0.11% 113
2018
Q3
$1.46M Sell
7,690
-711
-8% -$131K 0.27% 75
2018
Q2
$1.4M Sell
8,401
-12,652
-60% -$2.03M 0.28% 76
2018
Q1
$3.54M Sell
21,053
-3,687
-15% -$618K 0.73% 46
2017
Q4
$4.05M Sell
24,740
-2,105
-8% -$378K 0.86% 43
2017
Q3
$5.5M Buy
26,845
+935
+4% +$217K 1.2% 29
2017
Q2
$6.3M Buy
25,910
+2,600
+11% +$611K 1.42% 23
2017
Q1
$5.57M Buy
23,310
+8,069
+53% +$1.88M 1.28% 30
2016
Q4
$3.2M Buy
15,241
+1,415
+10% +$293K 0.8% 48
2016
Q3
$3.18M Buy
13,826
+1,490
+12% +$364K 0.81% 50
2016
Q2
$2.85M Buy
12,336
+4,729
+62% +$1.09M 0.74% 49
2016
Q1
$2.04M Buy
7,607
+634
+9% +$181K 0.55% 55
2015
Q4
$2.18M Buy
6,973
+4,458
+177% +$1.33M 0.59% 56
2015
Q3
$684K Buy
2,515
+1,840
+273% +$565K 0.2% 91
2015
Q2
$205K Buy
+675
New +$201K 0.05% 140

Other funds holding AGN

Adell Harriman & Carpenter's AGN Position: Q1 2019 in Review

Adell Harriman & Carpenter sold out of Allergan plc (AGN) in Q1 2019, closing a stake of 3,621 shares — an estimated $484K sold.

Adell Harriman & Carpenter first reported a position in AGN in Q2 2015 and held it in 15 quarters. The position peaked at $6.3M in Q2 2017. 991 funds tracked by Wall St. Rank hold AGN as of Q1 2019.

  • Adell Harriman & Carpenter reported no remaining Allergan plc position as of Q1 2019 after selling out during the quarter.
  • Adell Harriman & Carpenter sold 3,621 Allergan plc shares in Q1 2019, an estimated $484K.
  • Adell Harriman & Carpenter first reported a position in Allergan plc in Q2 2015 and held it in 15 quarters.
  • Adell Harriman & Carpenter's Allergan plc position peaked at $6.3M in Q2 2017.
  • 991 funds tracked by Wall St. Rank held Allergan plc as of Q1 2019.

Based on Adell Harriman & Carpenter's 13F filing for Q1 2019, filed 7 May 2019.